The impact of prophylactic axillary node dissection on breast cancer survival - A Bayesian meta-analysis

Annals of Surgical Oncology

Volumn 6, Issue 1, 1999, Pages 109-116

  Orr, Richard K ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Axillary lymphadenectomy; Breast neoplasms

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BAYES THEOREM; BREAST CANCER; CANCER SURVIVAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MASTECTOMY; META ANALYSIS; RECURRENT DISEASE; SURVIVAL TIME; TREATMENT PLANNING;

AXILLA; BAYES THEOREM; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY;

EID: 0033022675     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0109-1     Document Type: Article

References (57)

1. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-4.
2. Ruffin WK, Stacey-Clear A, Younger J, Hoover HC Jr. Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg 1995;180:245-51.
3. Balch CM, Singletary SE, Bland KI. Clinical decision-making in early breast cancer. Ann Surg 1993;217:207-25.
4. Eberlein TJ Current management of carcinoma of the breast. Ann Surg 1994;220:121-36.
5. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
6. Dees EC, Shulman LN, Souba WW, Smith BL. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg 1997;226:279-86.
7. Hayward J, Caleffi M. The significance of local control in the primary treatment of breast cancer. Arch Surg 1987;122:1244-7.
8. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993;218:338-49.
9. Deckers PJ. Axillary dissection in breast cancer: when, why, how much, and for how long? Another operation soon to be extinct? J Surg Oncol 1991;48:217-9.
10. Haffty BC, McKhann C, Beinfield M, Fischer D, Fischer JJ. Breast conservation therapy without axillary dissection: A rational treatment strategy in selected patients. Arch Surg 1993;12:1315-9.
11. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colbum WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma: Is it indicated? Cancer 1994;73:664-7.
12. Hoe AL, Iven D, Royle GT, Taylor I. Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 1992;79: 261-2.
13. Aitken RJ, Gaze MN, Rodger A, Chetty U, Forrest APM. Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance. Br J Surg 1989; 76:568-71.
14. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-8.
15. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992;50:47-52.
16. Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med 1992;93:543-8.
17. Clarke D, Martinez A, Cox RS, Goffinet DR. Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer 1982;49:2295-9.
18. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11:1536-44.
19. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-81.
20. Gardner B, Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg 1993;218:270-8.
21. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985; 5:17-21.
22. Recht A, Houlihan MJ. Axillary lymph nodes in breast cancer - a review. Cancer 1995;76:1491-1512.
23. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer - An overview of the randomized trials. N Engl J Med 1995;333:1444-55.
24. Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987;71:15-29.
25. Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 1987;71:7-14.
26. Brinkley D, Haybittle JL. Treatment of Stage-II carcinoma of the female breast. Lancet 1966;2:291-5.
27. Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer. Vol. 1. Worldwide evidence 1985-1990. Oxford: Oxford University Press, 1990.
28. Johansen H, Kaae S, Schiodt T. Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer: A twenty-five year follow-up of a randomized trial. Acta Oncol 1990;29:709-15.
29. Kaae S, Johansen H. Does simple mastectomy followed by irradiation offer survival comparable to radical procedures? Int J Radiation Oncol Biophys 1977;2:1163-6.
30. Bruce J. Operable cancer of the breast - A controlled clinical trial. Cancer 1971;28:1443-52.
31. Hamilton T, Langlands AO, Prescott RJ. The treatment of operable cancer of the breast: a clinical trial in the South-East region of Scotland. Br J Surg 1974;61:758-61.
32. Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable cancer of the breast. Br J Surg 1980;67: 170-4.
33. Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer: A report after ten years of a clinical trial. Br Med J 1972;2:423-9.
34. Hayward JL. The Guy's trial of treatments of "early" breast cancer. World J Surg 1977;1:314-6.
35. Hayward JI. The Guy's Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W, eds. Consenvtire management of breast cancer: new surgical and radiotherapeutic techniques. Philadelphia: JB Lippincott, 1983:77-90.
36. Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-8.
37. Overgaard M, Christensen JJ, Johansen H. Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DCBC 82) trial. Int J Radiation Oncol Biol Phys 1990;19:1121-4.
38. Turnbull AR, Chant ADB, Buchanan RB, Turner DTL, Shepherd JM, Fraser JD. Treatment of early breast cancer. Lancet 1978;2: 7-9.
39. Lythgoe JP, Palmer MK. Manchester regional breast study - 5 and 10 year results. Br J Surg 1982;69:693-6.
40. Houghton J, Baum M, Haybittle JL. Role of radiotherapy following total mastectomy in patients with early breast cancer. World J Surg 1994;18:117-22.
41. Helman P, Bennett M B, Louw JH, et al. Interim report on trial of treatment for operable breast cancer. S Afr Med J 1972;46:1374-5.
42. Dent DM, Gudgeon CA, Murray EM. Mastectomy with axillary clearance versus mastectomy without it. Late results of a trial in which patients had no adjuvant chemo-, radio- or endocrine therapy. J Afr Med J 1996;86:670-1.
43. Forrest APM, Everington D, McDonald CC, Steele RJC, Chetty U, Stewart HJ. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg 1995;82:1504-8.
44. Raudenbush SW. Random effects models. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York: Russell Sage Foundation, 1994:301-22.
45. Brophy JM, Joseph L. Placing trials in context using Bayesian analysis - GUSTO revisited by Reverend Bayes. JAMA 1995;273: 871-5.
46. Lewis RJ, Wears RL. An introduction to the Bayesian analysis of clinical trials. Ann Emerg Med 1993;22:1328-36.
47. Eddy DM, Hasselblad V, Schachter R. An introduction to a Bayesian method for meta-analysis: the Confidence Profile method. Med Decis Making 1990;10:15-23.
48. Eddy DM, Hasselblad V, Schachter R. A Bayesian method for synthesizing evidence: The Confidence Profile method. Int J Technology Assessment Health Care 1990;6:31-55.
49. Eddy DM, Hasselblad V, Schachter R. Meta-analysis by the Confidence Profile Method. Boston: Academic Press, 1992.
50. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;107:224-33.
51. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992;339:1-15, 71-85.
52. Rockette HE, Redmond CK. Limitations and advantages of metaanalysis in clinical trials. Rec Results Cancer Research 1988;111: 99-104.
53. Levitt SH, Aeppli DM, Nierengarten ME. The impact of radiation on early breast carcinoma survival - A Bayesian analysis. Cancer 1996;78:1035-42.
54. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985;312:665-73.
55. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographie screening. Arch Surg 1996;131:301-8.
56. Fisher B, Brown A, Mamounas, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483-93.
57. Mustafa IA, Bland KI. Indications for axillary dissection in T1 breast cancer. Ann Surg Oncol 1998;5:23-7.